Get started
Author

Romaana Mir

Organ at risk delineation for radiation therapy clinical trials: Global Harmonization Group consensus guidelines
2020 · Romaana Mir, Sarah M. Kelly, et al. · Radiotherapy and Oncology · 125
PDF
Metformin for patients with metastatic prostate cancer starting androgen deprivation therapy: a randomised phase 3 trial of the STAMPEDE platform protocol
2025 · Silke Gillessen, Laura Murphy, et al. · The Lancet Oncology · 35
PDF
Mycophenolate mofetil alongside high-dose corticosteroids: optimizing the management of combination immune checkpoint inhibitor-induced colitis
2018 · Romaana Mir, Heather M. Shaw, et al. · Melanoma Research · 32
The Evolving Role of Artificial Intelligence in Radiotherapy Treatment Planning—A Literature Review
2024 · S. Kalsi, H. French, et al. · Clinical Oncology · 22
Sacral Insufficiency Fracture Following Pelvic Radiotherapy in Gynaecological Malignancies: Development of a Predictive Model
2020 · R. Mir, A.D. Dragan, et al. · Clinical Oncology · 21
Provision of Organ at Risk Contouring Guidance in UK Radiotherapy Clinical Trials
2019 · H. Yang, R. Mir, et al. · Clinical Oncology · 13
Automatic evaluation of contours in radiotherapy planning utilising conformity indices and machine learning
2020 · Samsara Terparia, Romaana Mir, et al. · Physics and Imaging in Radiation Oncology · 12
PDF
Plasma AR Alterations and Timing of Intensified Hormone Treatment for Prostate Cancer: the STAMPEDE Phase 3 Randomized Clinical Trial
2025 · Gianmarco Leone, Francesco Orlando, et al. · JAMA Oncology · 9
Quality of life issues faced by patients with keratinocyte cancer: A systematic review
2024 · Samantha K.F. Kennedy, Shing-Fung Lee, et al. · EJC Skin Cancer · 9
PDF
Clinical Oncology Training: The Trainees’ Perspective
2011 · M. Lei, J. Stokoe, et al. · Clinical Oncology · 9
PDF
Challenges and opportunities for real-world evidence in clinical oncology—a view from the UK: proceedings of a national workshop
2024 · M. Craddock, C. Dempsey, et al. · ESMO Real World Data and Digital Oncology · 6
PDF
Immunosuppressive Agents and Their Role in Managing Immunotherapy Toxicities in Melanoma
2017 · Romaana Mir, Heather M. Shaw, et al. · Clinical skin cancer · 6
Association between radiotherapy protocol variations and outcome in the CONVERT trial
2022 · Romaana Mir, Nicki Groom, et al. · Clinical and Translational Radiation Oncology · 5
PDF
Axillary management in T1-3N1M0 breast cancer patients with needle biopsy proven nodal metastases at presentation after neoadjuvant chemotherapy (ATNEC).
2021 · Amit Goyal, Sophie Cramp, et al. · Journal of Clinical Oncology · 5
Abstract OT1-04-01: ATNEC: A multi-centre, randomised trial investigating whether axillary treatment can be avoided in T1-3N1M0 breast cancer patients with no residual cancer in the lymph glands after neoadjuvant chemotherapy (clinicaltrials.gov: nct04109079)
2022 · Amit Goyal, Sophie Cramp, et al. · Cancer Research · 4
The benzodiazepine problem in primary care: the seriousness and solutions
2005 · Perminderjit Singh Dhahan, Romaana Mir · Quality in primary care · 4
Feasibility and safety results from RAD-IO: A multi-stage trial of durvalumab with chemoradiotherapy with 5-fluorouracil and mitomycin C in patients with muscle-invasive bladder cancer.
2026 · Nicholas David James, Joseph van de Wiel, et al. · Journal of Clinical Oncology · 2
Regional Lymph Node Delineation variability and its Dosimetric Impact in Breast Cancer Radiotherapy
2025 · Z. Nabi, D. Megias, et al. · Clinical Oncology · 2
Cumulative corticosteroid exposure in patients experiencing checkpoint inhibitor toxicity.
2017 · Romaana Mir, Heather May Shaw, et al. · Journal of Clinical Oncology · 2
Abstract OT-04-01: Axillary management in T1-3N1M0 breast cancer patients with needle biopsy proven nodal metastases at presentation after neoadjuvant chemotherapy - ATNEC (ClinicalTrials.gov NCT04109079)
2021 · Amit Goyal, Sophie Cramp, et al. · Cancer Research · 1
PO-1294: Consistency of OAR delineation for clinical trials: A Global Harmonization Group Consensus
2020 · R. Mir, S. Kelly, et al. · Radiotherapy and Oncology · 1
P-177 Stereotactic Radiotherapy (SRT) versus Whole Brain Radiotherapy (WBRT) in the management of 1-3 brain metastases (BM) originating from a gastrointestinal (GI) tract malignancy
2016 · P.S. Lim, R. Mir, et al. · Annals of Oncology · 1
What Factors Contribute to Late Rectal Toxicity after Prostate Radiotherapy
2014 · R. Mir, E. Larbi, et al. · Clinical Oncology · 1
Facilitating the interpretation of individual patient-reported outcomes: thresholds for clinical importance for the EORTC colorectal cancer module (EORTC QLQ-CR29)
2026 · Kelly M. de Ligt, Micha J. Pilz, et al. · Journal of Clinical Epidemiology
PDF
From patient-reported outcome scores to clinical meaning: defining thresholds for clinical importance for the EORTC QLQ-PR25 questionnaire for patients with prostate cancer
2026 · Samuel M. Vorbach, Micha J. Pilz, et al. · Radiotherapy and Oncology
PDF
Works count: 57
Citation count: 327
H-index: 9
I10-index: 7
Year
Topic
Type